‘Mismatched’ transplants now safe, effective for blood cancer patients, study finds (IMAGE)

University of Virginia Health System

‘Mismatched’ transplants now safe, effective for blood cancer patients, study finds

Caption

"All patients, regardless of background, now have a stem cell or bone marrow transplant donor, a significant advance for our field, our patients and our community,” said Karen Ballen, MD, UVA Health’s Chief of Hematology/Oncology and Medical Director of Stem Cell Transplant. 

 

Credit

UVA Health

Usage Restrictions

May be used to accompany news coverage of the mismatched transplant study. All other uses require express written permission from UVA Health.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.